MENU
+Compare
BNR
Stock ticker: NASDAQ
AS OF
Jun 30, 12:32 PM (EDT)
Price
$3.16
Change
+$0.10 (+3.27%)
Capitalization
74.76M

BNR Burning Rock Biotech Limited Forecast, Technical & Fundamental Analysis

Burning Rock Biotech Ltd is a cancer diagnostics company... Show more

BNR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BNR with price predictions
Jun 27, 2025

BNR in upward trend: 10-day moving average crossed above 50-day moving average on June 10, 2025

The 10-day moving average for BNR crossed bullishly above the 50-day moving average on June 10, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

BNR moved above its 50-day moving average on June 10, 2025 date and that indicates a change from a downward trend to an upward trend.

The Aroon Indicator entered an Uptrend today. In of 90 cases where BNR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for BNR moved out of overbought territory on June 13, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 19 similar instances where the indicator moved out of overbought territory. In of the 19 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on June 27, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BNR as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for BNR turned negative on June 27, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

BNR broke above its upper Bollinger Band on June 12, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.593) is normal, around the industry mean (24.463). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.913) is also within normal values, averaging (43.062).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BNR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BNR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
BNR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BNR is expected to report earnings to fall 86.02% to -110 cents per share on May 28

Burning Rock Biotech Limited BNR Stock Earnings Reports
Q1'24
Est.
$-1.10
Q4'24
Missed
by $6.85
Q4'23
Missed
by $0.29
Q3'23
Missed
by $0.39
Q2'23
Beat
by $0.09
The last earnings report on March 25 showed earnings per share of -786 cents, missing the estimate of -101 cents. With 3.68K shares outstanding, the current market capitalization sits at 74.76M.
A.I. Advisor
published General Information

General Information

a company, which engages in the investment of medical fields and specializes in next-generation sequencing diagnostics solutions for precision medicine in oncology

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
No. 5, Xingdao Ring Road North
Phone
+86 2034037871
Employees
1138
Web
https://www.brbiotech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BURBY15.660.86
+5.81%
Burberry Group Plc
LNSPF2.73N/A
N/A
London & Stamford Property PLC
MTGRY2.20N/A
N/A
Mount Gibson Iron Ltd.
FNMAL21.25N/A
N/A
Fannie Mae
BIRMF1.57-0.13
-7.65%
Biorem, Inc.

BNR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BNR has been closely correlated with SSKN. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if BNR jumps, then SSKN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNR
1D Price
Change %
BNR100%
-10.26%
SSKN - BNR
86%
Closely correlated
-3.85%
APDN - BNR
85%
Closely correlated
+6.98%
SINT - BNR
25%
Poorly correlated
+1.90%
ACRS - BNR
24%
Poorly correlated
N/A
ALGN - BNR
22%
Poorly correlated
+0.42%
More

Groups containing BNR

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNR
1D Price
Change %
BNR100%
-10.26%
BNR
(5 stocks)
-1%
Poorly correlated
+0.31%